Protagonist Therapeutics
PTGX
$26.09
Share price
2.15%
Change (1 day)
10.55%
Change (1 year)
Categories
Protagonist Therapeutics (PTGX) - Cash on Hand
Cash on Hand as of December 2023 : $0.34 B
According to Protagonist Therapeutics
's latest financial reports the company has $0.34 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Protagonist Therapeutics - Cash on Hand chart (from 2015 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.34 B | 43.93% |
| 2022-12-31 | $0.23 B | -27.39% |
| 2021-12-31 | $0.32 B | 6.9% |
| 2020-12-31 | $0.30 B | 129.9% |
| 2019-12-31 | $0.13 B | 3.23% |
| 2018-12-31 | $0.12 B | -10.52% |
| 2017-12-31 | $0.14 B | 85.57% |
| 2016-12-31 | $77.59 M | 550.83% |
| 2015-12-31 | $11.92 M | 27.87% |
| 2014-12-31 | $9.32 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -39.06% | 🇺🇸 USA |